PubMed · 1979 · 33 citations · 0 references
MedicineNuclear MedicineRadiologyBone ScintigraphyDiagnostic ImagingDiagnostic RadiologyBone MetastasisBone Metastasis ImagingBone Tumor ImagingBone TumorsMetastatic Bone DiseaseTumor ImagingLesion DetectionMetastatic Bone Disease DetectionMetastatic Bone Lesion ImagingRadionuclide Bone ImagingTc-99m Bone ScintigraphyTc-99m Methylene Diphosphonate ImagingTechnetium-99m Methylene Diphosphonate ImagingTechnetium-99m Phosphate Imaging
We have compared bone scintigrams made with Tc-99m-tagged HEDP (1-hydroxyethylidene diphosphonate)and MDP (methylene diphosphonate), the former at 4 hr after injection, the latter at both 2 and 4 hr. In 17 patients with skeletal metastases, there was no significant difference in lesion count or scan quality between the 4-hr images. The tumor-to-bone ratio (T/B) was significantly higher with Tc-HEDP (p less than 0.02). Lesion detection rate and T/B ratios were both lower with Tc-MDP at 2 hr when compared with the 4-hr values for both Tc-HEDP (p less than 0.02, p less than 0.005) and Tc-MDP (p less than 0.02, p less than 0.01). The 4-hr Tc-MDP scan was of significantly higher quality than the 2 hr Tc-MDP scan (p less than 0.01). Although Tc-HEDP produces a higher T/B ratio at 4 hr, the present study does not suggest that either agent is superior in clinical practice.